These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 32679814)
1. Coumarin Ameliorates Impaired Bone Turnover by Inhibiting the Formation of Advanced Glycation End Products in Diabetic Osteoblasts and Osteoclasts. Lee EJ; Kang MK; Kim YH; Kim DY; Oh H; Kim SI; Oh SY; Na W; Kang YH Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32679814 [TBL] [Abstract][Full Text] [Related]
2. Effects of Advanced Glycation End Products on Differentiation and Function of Osteoblasts and Osteoclasts. Park SY; Choi KH; Jun JE; Chung HY J Korean Med Sci; 2021 Sep; 36(37):e239. PubMed ID: 34581519 [TBL] [Abstract][Full Text] [Related]
3. Osteoblastogenesis and osteoprotection enhanced by flavonolignan silibinin in osteoblasts and osteoclasts. Kim JL; Kang SW; Kang MK; Gong JH; Lee ES; Han SJ; Kang YH J Cell Biochem; 2012 Jan; 113(1):247-59. PubMed ID: 21898547 [TBL] [Abstract][Full Text] [Related]
4. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation. Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673 [TBL] [Abstract][Full Text] [Related]
5. Osteoblastic γ-aminobutyric acid, type B receptors negatively regulate osteoblastogenesis toward disturbance of osteoclastogenesis mediated by receptor activator of nuclear factor κB ligand in mouse bone. Takahata Y; Takarada T; Hinoi E; Nakamura Y; Fujita H; Yoneda Y J Biol Chem; 2011 Sep; 286(38):32906-17. PubMed ID: 21828041 [TBL] [Abstract][Full Text] [Related]
6. Macrolactin F inhibits RANKL-mediated osteoclastogenesis by suppressing Akt, MAPK and NFATc1 pathways and promotes osteoblastogenesis through a BMP-2/smad/Akt/Runx2 signaling pathway. Li L; Sapkota M; Gao M; Choi H; Soh Y Eur J Pharmacol; 2017 Nov; 815():202-209. PubMed ID: 28919027 [TBL] [Abstract][Full Text] [Related]
7. Direct inhibitory and indirect stimulatory effects of RAGE ligand S100 on sRANKL-induced osteoclastogenesis. Yoshida T; Flegler A; Kozlov A; Stern PH J Cell Biochem; 2009 Aug; 107(5):917-25. PubMed ID: 19415676 [TBL] [Abstract][Full Text] [Related]
8. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse. Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637 [TBL] [Abstract][Full Text] [Related]
10. Effects of vascular endothelial growth factor on osteoblasts and osteoclasts. Huang H; Ma L; Kyrkanides S Am J Orthod Dentofacial Orthop; 2016 Mar; 149(3):366-73. PubMed ID: 26926024 [TBL] [Abstract][Full Text] [Related]
11. Advanced glycation end products affect growth and function of osteoblasts. Franke S; Rüster C; Pester J; Hofmann G; Oelzner P; Wolf G Clin Exp Rheumatol; 2011; 29(4):650-60. PubMed ID: 21906430 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of hormone and cytokine-stimulated osteoclastogenesis and bone resorption by interleukin-4 and interleukin-13 is associated with increased osteoprotegerin and decreased RANKL and RANK in a STAT6-dependent pathway. Palmqvist P; Lundberg P; Persson E; Johansson A; Lundgren I; Lie A; Conaway HH; Lerner UH J Biol Chem; 2006 Feb; 281(5):2414-29. PubMed ID: 16251181 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-17A induces cathepsin K and MMP-9 expression in osteoclasts via celecoxib-blocked prostaglandin E2 in osteoblasts. Zhang F; Tanaka H; Kawato T; Kitami S; Nakai K; Motohashi M; Suzuki N; Wang CL; Ochiai K; Isokawa K; Maeno M Biochimie; 2011 Feb; 93(2):296-305. PubMed ID: 20937352 [TBL] [Abstract][Full Text] [Related]
14. Zebrafish scales respond differently to in vitro dynamic and static acceleration: analysis of interaction between osteoblasts and osteoclasts. Kitamura K; Takahira K; Inari M; Satoh Y; Hayakawa K; Tabuchi Y; Ogai K; Nishiuchi T; Kondo T; Mikuni-Takagaki Y; Chen W; Hattori A; Suzuki N Comp Biochem Physiol A Mol Integr Physiol; 2013 Sep; 166(1):74-80. PubMed ID: 23632157 [TBL] [Abstract][Full Text] [Related]
15. Advanced glycation endproducts influence the mRNA expression of RAGE, RANKL and various osteoblastic genes in human osteoblasts. Franke S; Siggelkow H; Wolf G; Hein G Arch Physiol Biochem; 2007 Jun; 113(3):154-61. PubMed ID: 17922311 [TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-alpha cooperates with receptor activator of nuclear factor kappaB ligand in generation of osteoclasts in stromal cell-depleted rat bone marrow cell culture. Komine M; Kukita A; Kukita T; Ogata Y; Hotokebuchi T; Kohashi O Bone; 2001 May; 28(5):474-83. PubMed ID: 11344046 [TBL] [Abstract][Full Text] [Related]
17. Continuous elevation of PTH increases the number of osteoblasts via both osteoclast-dependent and -independent mechanisms. Jilka RL; O'Brien CA; Bartell SM; Weinstein RS; Manolagas SC J Bone Miner Res; 2010 Nov; 25(11):2427-37. PubMed ID: 20533302 [TBL] [Abstract][Full Text] [Related]
18. Coenzyme q10 regulates osteoclast and osteoblast differentiation. Moon HJ; Ko WK; Jung MS; Kim JH; Lee WJ; Park KS; Heo JK; Bang JB; Kwon IK J Food Sci; 2013 May; 78(5):H785-891. PubMed ID: 23582186 [TBL] [Abstract][Full Text] [Related]
19. Hydroxycoumarin Scopoletin Inhibits Bone Loss through Enhancing Induction of Bone Turnover Markers in a Mouse Model of Type 2 Diabetes. Lee EJ; Na W; Kang MK; Kim YH; Kim DY; Oh H; Kim SI; Oh SY; Park S; Park K; Kang YH Biomedicines; 2021 Jun; 9(6):. PubMed ID: 34200167 [TBL] [Abstract][Full Text] [Related]
20. A comparative study on BMP-induced osteoclastogenesis and osteoblastogenesis in primary cultures of adult rat bone marrow cells. Paul S; Lee JC; Yeh LC Growth Factors; 2009 Apr; 27(2):121-31. PubMed ID: 19180354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]